Depixus

BiotechnologySeries AParis, Francedepixus.com

Latest round

Series A

Last raised

Apr 2021

Total raised

$22M

Investors

3

About Depixus

Founded in 2012 and headquartered in Paris, France, Depixus SAS focuses on biomolecular analysis.Depixus specializes in advanced biomolecular analysis through its flagship product, the MAGNA One, which employs magnetic force spectroscopy (MFS) to visualize molecular interactions in real-time. This platform allows researchers to observe thousands of individual biomolecular interactions, significantly enhancing insights into molecular dynamics and heterogeneity.Depixus generates revenue primarily through the sale and installation of its MAGNA One instruments and associated services. Revenue streams include direct sales to research institutions, maintenance agreements, and subscription-based access to software tools. The company is strategically planning to expand its operational reach into new markets and geographic regions, although specific details on these expansions have yet to be disclosed.

Who invested in Depixus

3 investors across 1 round

See all investors in Depixus

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 9, 2021

    Amount

    $22M

    Investors

    Locked

Questions about Depixus

Who invested in Depixus?

Depixus has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Depixus raised?

Depixus has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Depixus last raise money?

Depixus's most recent round on record is a Series A, in Apr 2021.

What does Depixus do?

Founded in 2012 and headquartered in Paris, France, Depixus SAS focuses on biomolecular analysis.

Where is Depixus headquartered?

Depixus is headquartered in Paris, France.

Which VCs invest in companies like Depixus?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Depixus's stage. Their profiles are linked below.

Raising like Depixus? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.